Suppr超能文献

糖蛋白IIb/IIIa受体拮抗剂的酯型前药ME3229的单酸和二酸代谢物在大鼠小肠中的极化外排。

Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.

作者信息

Okudaira N, Komiya I, Sugiyama Y

机构信息

Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Yokohama, Japan.

出版信息

J Pharmacol Exp Ther. 2000 Nov;295(2):717-23.

Abstract

ME3229 is an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist ME3277. In our previous study, it was shown that only a small part of the drug taken up into the enterocytes reached the mesenteric vein, mainly due to transporter-mediated efflux of its hydrolyzed metabolites formed in the cells. To characterize the efflux transport system for the metabolites, the transport of the diacid metabolite ME3277 and the monoacid metabolites PM-10 and PM-11 were studied. ME3277 and PM-10 were preferentially transported in the serosal-to-mucosal direction across the rat small intestine in the presence of glucose. Permeability of ME3277 across monolayer of Caco-2 cells with P-glycoprotein (P-gp) and indomethacin-sensitive efflux pump expression did not show any directionality and verapamil, an inhibitor of P-gp, and indomethacin did not affect the permeability of ME3277 across rat intestinal tissue. Directional transport was not site specific and was observed in the Eisai hyperbilirubinemic rat whose canalicular multispecific organic anion transporter/multidrug resistance-associated protein (cMOAT/MRP2) is hereditarily defective as well as in normal rats. The efflux transport of ME3277 was inhibited by 1-naphthol, 1-choloro-2,4-dinitrobenzene, and sulfobromophthalein, and efflux of ME3277 and monoacid metabolites from intestinal tissue preloaded with ME3229 fell in the presence of 1-naphthol and sulfobromophthalein. These results demonstrate that mono- and diacid metabolites of ME3229 were pumped out into the gut lumen by an energy-dependent transport system located on the mucosal membrane of intestinal tissue and distinct from either P-gp, indomethacin-sensitive efflux pump or canalicular multispecific organic anion transporter/MRP2. An inhibition study suggested that this unknown transporter has a substrate specificity similar to that of MRP transporter families.

摘要

ME3229是糖蛋白IIb/IIIa受体拮抗剂ME3277的酯型前药。在我们之前的研究中发现,进入肠细胞的药物只有一小部分到达肠系膜静脉,这主要是由于细胞内形成的水解代谢产物通过转运体介导的外排作用。为了表征代谢产物的外排转运系统,研究了二酸代谢产物ME3277以及单酸代谢产物PM - 10和PM - 11的转运情况。在葡萄糖存在的情况下,ME3277和PM - 10优先从浆膜向黏膜方向穿过大鼠小肠。ME3277在具有P - 糖蛋白(P - gp)和吲哚美辛敏感外排泵表达的Caco - 2细胞单层上的通透性没有显示出任何方向性,P - gp抑制剂维拉帕米和吲哚美辛均不影响ME3277穿过大鼠肠道组织的通透性。方向性转运并非位点特异性的,在小管多特异性有机阴离子转运体/多药耐药相关蛋白(cMOAT/MRP2)遗传性缺陷的卫材高胆红素血症大鼠以及正常大鼠中均观察到了这种现象。ME3277的外排转运受到1 - 萘酚、1 - 氯 - 2,4 - 二硝基苯和磺溴酞的抑制,并且在1 - 萘酚和磺溴酞存在的情况下,预先加载ME3229后肠组织中ME3277和单酸代谢产物的外排减少。这些结果表明ME3229的单酸和二酸代谢产物通过位于肠道组织黏膜膜上的能量依赖性转运系统被泵入肠腔,该转运系统不同于P - gp、吲哚美辛敏感外排泵或小管多特异性有机阴离子转运体/MRP2。一项抑制研究表明,这种未知的转运体具有与MRP转运体家族相似的底物特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验